$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[국내논문] 고지방식이로 유발된 비만에 대한 택사의 항비만 효과
Efficacy of Alismatis Orientale Rhizoma on Obesity induced by High Fat Diet 원문보기

大韓本草學會誌 = The Korea journal of herbology, v.28 no.3, 2013년, pp.95 - 106  

정향숙 (대구한의대학교 대학원 노인의료복지학과 노인의료복지전공)

Abstract AI-Helper 아이콘AI-Helper

Objectives : The researcher investigated the anti-obesity effect of Alismatis Orientale Rhizoma(AP) water extract in mice fed a high fat diet and focused on the analysis of local area adipose tissue. Methods : Male ICR mice were divided into three groups, which were fed either a normal AIN diet, a 4...

주제어

질의응답

핵심어 질문 논문에서 추출한 답변
비만이나 과체중이란? WHO1)에 의하면, 비만이나 과체중은 건강을 손상할 수 있을 정도로 비정상적이거나 과도하게 지방이 축적된 상태를 의미한다. 비만은 에너지 섭취가 소비보다 큰 에너지 대사의 불균형으로 발생한다2).
비만의 원인은? WHO1)에 의하면, 비만이나 과체중은 건강을 손상할 수 있을 정도로 비정상적이거나 과도하게 지방이 축적된 상태를 의미한다. 비만은 에너지 섭취가 소비보다 큰 에너지 대사의 불균형으로 발생한다2).
질의응답 정보가 도움이 되었나요?

참고문헌 (54)

  1. WHO. Obesity and overweight. Retrieved Oct. 19, 2012, from http://www.who.int/mediacentre/factsheets/fs311/en 

  2. Kopelman PG. Obesity as a medical problem. Nature. 2000 ; 404(6778) : 635-43. 

  3. Korea Centers for Disease Control & Prevention of Ministry of health and welfare. Retrieved Oct. 15, 2012, from http://knhanes.cdc.go.kr/knhanes/sub01/sub01_05.jsp#s5_01_10 

  4. Lee CW, Lee DH, Yoon JH. The Effects of Circuit Exercise Programs on Body Composition, Blood Lipid and Liver Function Variables in Elderly People with Obesity. Journal of Sport and Leisure Studies. 2011 ; 45(2):913-22. 

  5. Lee HY, Yoon KH, Seo BI, Park GR, Yoon MC, Shen ZB, Cui HH, Shin SS. Molecular biologic mechanism of obesity by GGEx18. Kor J Herbology. 2011 ; 26(1):65-74. 

  6. Kurt J. Isselbacher. Harrison's Principles of internal medicine. New York : McGraw-Hill. 1994:446-52. 

  7. Department of Internal medicine, medical college of Seoul national university. Internal medicine(내과학). Seoul : Gunja publishing. 1996:852-62. 

  8. Woo HC, Shin BK, Cho IJ, Kim MH, Han JH. Bioactive Materials:Anti-obesity Effect of Carbon Dioxide Supercritical Fluid Extracts of Panax Ginseng C. A. Meyer. J Korean Soc Appl Biol Chem. 2011;54(5):738-43. 

  9. Kim JY, Song YS. A bibliographic Study about comparison of Eastern-Western medicine on obesity. Journal of Oriental Rehabilitation Medicine. 1993 ; 3(1):299-314. 

  10. Shin IS, Choi HM, Ku SK, Kim MR. The effect of natural mixture supplementation on histopathological and histomorphometrical aspects in high fat diet-induced obese mice. Kor J Herbology. 2012 ; 27(4):53-8. 

  11. The textbook compilation committee of Korean herbology. Korean herbology. Seoul : Younglimsa. 2011:348-9. 

  12. Seo BI, Jeong GY. The easily understanding herbology. Kyungsan:publishing department of Dagu Haany university. 2012 : 185-6. 

  13. Lim SJ, Kim SH. The Effect of Each Fraction of Methanol Extract of Alisma canaliculatum on Blood Glucose Levels and Lipid Metabolism in Streptozotocin Induced Diabetic Rats. Korean J Nutr. 2001;34(6):619-25. 

  14. Lee JC, Lee E, Lee YC. Effects of Rhizoma Alismatis on Lipid Composition and TBARS Concentration in Rat Fed High Fat Diet. Kor J Herbology 2008 ; 23(3):113-7. 

  15. Chung Ae Toh. Original Articles:Antimicrobial and Antifungal Studies on Alismae Rhizoma. Kor J Pharmacogn. 1996 ; 27(4):378-82. 

  16. Chang IM, Kim YS, Yun HS, Kim SO. Liver-protective Activities of Alisol Compounds against CCl4 Intoxication. Kor J Pharmacogn. 1982 ; 13(3):112-5. 

  17. Choi JS, Park SD, Byun JS. Experimental Study on the Effects of Alismatis Rhizoma on Hyperlipidemia. K.I.M.S. 1998 ; 19(2):392-410. 

  18. Lee SM, Kim JH, Zhang Y, An RB, Min BS, Joung H, Lee HY. Anticomplementary activity of protostane-type triterpenes from Alismatis rhizoma. Arch Pharm Res. 2003 ; 26:463-5. 

  19. Fong WF, Wang C, Zhu GY, Leung CH, Yang MS, Cheung HY. Reversal of multidrug resistance in cancer cells by Rhizoma Alismatis extract. Phytomedicine. 2007 ; 14(2-3):160-5. 

  20. Kubo M, Matsuda H, Tomohiro N and Yoshikawa M. Studies on Alismatis rhizoma. I. Anti-allergic effects of methanol extract and six terpene components from Alismatis rhizoma (dried rhizome of Alisma orientale). Biol Pharm Bull. 1997 ; 20(5): 511-6. 

  21. Nasr SZ, Drury D. Appetite stimulants use n cystic fibrosis. Pediatr Pulmonol. 2008 ; 43(3):209-19. 

  22. Naderali EK, Williams G. Prolonged endothelial-dependent and independent arterial dysfunction induced in the rat by short-term feeding with a high-fat, high-sucrose diet. Atherosclerosis. 2003 ; 166(2):253-9. 

  23. Yilmaz A, Suleyman H, Umudum Z, Sahin Y.N. The effect of adrenalectomy on leptin levels and some metabolic parameters in rats with diet-induced obesity. Biol Pharm Bull. 2002 ; 25(5):580-3. 

  24. Kim BH, Seo BI, Lee ES, Kim MR, Shin SS. The effects of Aurantii Fructus Immaturus and Persicae Semen on an obesity of rats fed high fat diet. Kor J Herbology. 2003 ; 18(3):69-78. 

  25. Han SC, Cha SW, Suh JE, Suh KH. Original Articles:Single Oral Dose Toxicity of a New Salt of Sibutramine, Sibutramine Mesilate Hemihydrate, in Rats and Beagle Dogs. The Korean J Lab Anim Sci. 2004 ; 20(4):409-18. 

  26. Ha YJ, Han YJ, Won Choi YW, Myung KB, Choi HY. Sibutramine (Reductil(R))-Induced Cutaneous Leukocytoclastic Vasculitis:A Case Report. Annals of Dermatology. 2011 ; 23(4):544-7. 

  27. Karamadoukis L, Shivashankar GH, Ludeman L, Williams AJ. An unusual complication of treatment with orlistat. Clin Nephrol. 2009 ; 71(4):430-2. 

  28. Thurairajah PH, Syn WK, Neil DA, Stell D, Haydon G. Orlistat(Xenical)-induced subacute liver failure. Eur J Gastoenterol Hepatol. 2005 ; 17(12):1437-8. 

  29. Murata T, Imai Y, Hirata T, Miyamoto M. Biological-active trieterpenes of Alismatis rhizoma. I. Isolation of the alisols. Chem Pharm Bull (Tokyo). 1970 ; 18(7):1347-53. 

  30. Fukuyama Y, Pei-Wu G, Rei W, Yamada T, Nakagawa K. 11-deoxyalisol C and alisol D:new protostane-type triterpenoids from Alisma plantago-aquatica. Planta Med. 1988 ; 54(5): 445-7. 

  31. Yoshikawa M, Yamaguchi S, Matsuda H, Kohda Y, Ishikawa H, Tanaka N, Yamahara J, Murakami N. Crude drugs from aquatic plants. IV. On the constituents of alismatis rhizoma. (2). Stereostructures of bioactive sesquiterpenes, alismol, alismoxide, orientalols A, B, and C, from Chinese alismatis rhizoma. Chem Pharm Bull (Tokyo). 1994 ; 42(9): 1813-6. 

  32. Park JC, Hur JM, Kim SE. Isolation and Quantitative Analysis of Alisol B 23-Acetate from the Rhizome of Alisma orientale. J Korean Soc Food Sci Nutr. 2005;34(2):243-6. 

  33. Lee SM, Kwon BM, Min BS. FPTase Inhibition Effect of Protostanes from Alismatis Rhizoma and Derivatives from Alisol B 23-acetate. Kor J Pharmacogn. 2011;42(3):218-22. 

  34. DiGirolamo M, Fine JB, Tagra K, Rossmanith R. Qualitative regional differences in adipose tissue growth and cellularity in male Wistar rats fed ad libitum. Am J Physiol. 1998 ; 274:1460-7. 

  35. Lee JM, Seo BI, Park JH, Roh SS. Effects of water extracts from Phyllostachys Folium on hyperlipidemia and liver damage induced by alcohol. Kor J Herbology. 2011 ; 26(3):31-6. 

  36. Goldberg IJ. Lipoprotein lipase and lipolysis:central roles in lipoprotein metabolism and atherogenesis. J Lipid Res. 1996 ; 37(4):693-707. 

  37. Morishita S, Saito T, Mishima Y, Mizutani A, Hirai Y, Koyama S, Kawakami M. Strains and species differences in experimental hyperlipidemia. Nihon Yakurigaku Zasshi. 1986 ; 87(3):259-64. 

  38. Yang DH, Kim CH, Jung JG, Jung HW, Choi CH. The Effects of Taeyeumjowee-tang and Taeyeumjoweebaemahwang-tang on Obese rats. Kor J Herbology. 2010;25(3):103-9. 

  39. Castelli WP, Garrison RJ, Willson PW, Abott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein -cholesterol levels. JAMA. 1986; 256:2835-8. 

  40. Park HS, Kang YJ, Shin ES. Serum Lipid Profiles and Diet Patterns in Obese Children in Seoul. The Korean J Obes. 1994 ; 3(1):47-54. 

  41. Kim S, Moustaid-Moussa N. Secretory, endocrine and autocrine/paracrine function of the adipocyte. J Nutr. 2000 ; 130(12):3110S-5S. 

  42. Considinev RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF. Serum immunoreactive-leptin concentrations in normal-weight and obese mans. N Engl J Med. 1996 ; 334(5):292-5. 

  43. Hwang KH, Ahn JY, Kim SA, Ha TY. Anti-obesity Effect of Berberine in Mice Fed a High Fat Diet. J Food Sci Nutr. 2009 ; 14(4): 298-302. 

  44. Lang K, Ratke J. Leptin and Adiponectin:new players in the field of tumor cell and leukocyte migration. Cell Commun Signal. 2009 ; 23(7):27. 

  45. Cooke JP, Oka RK. Does leptin cause vascular disease? Circulation. 2002 ; 106(15):1904-5. 

  46. Rhee J, Inoue Y, Yoon JC, Puigserver P, Fan M, Gonzalez FJ, Spiegelman BM. Regulation of hepatic fasting response by $PPAR\gamma$ coactivator- $1\alpha$ (PGC-1):requirement for hepatocyte nuclear factor $4\alpha$ in gluconeogenesis. Proc Nati Acad Sci U S A. 2003 ; 100(7):4012-7. 

  47. Boustead JN, Stadelmaier BT, Eeds AM, Wiebe PO, Svitek CA, Oeser JK, O'Brien RM. Hepatocyte nuclear factor- $4\alpha$ mediates the stimulatory effect of peroxisome proliferator-activated receptor $\gamma$ co-activator- $1\alpha$ (PGC- $1\alpha$ ) on glucose-6-phosphatase catalytic subunit gene transcription in H4IIE cells. Biochem J. 2003 ; 369(1):17-22. 

  48. Hofmann CA, Edwards CW 3rd, Hillman RM, Colca JR. Treatment of insulin-resistant mice with the oral antidiabetic agent pioglitazone:evaluation of liver GLUT2 and phosphoenolpyruvate carboxykinase expression. Endocrinology. 1992 ; 130(2):735-40. 

  49. Noguchi T, Matsuda T, Tomari Y, Yamada K, Imai E, Wang Z, Ikeda H, Tanaka T. The regulation of gene expression by insulin is differentially impaired in the liver of the genetically obese-hyperglycemic Wistar fatty rat. FEBS Lett. 1993 ; 328(1-2): 145-8. 

  50. Handschin C, Lin J, Rhee J, Peyer AK, Chin S, Wu PH, Meyer UA, Spiegelman BM. Nutritional regulation of hepatic heme biosynthesis and porphyria through PGC- $1\alpha$ . Cell. 2005 ; 122(4): 505-15. 

  51. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Kahn CR, Granner DK, Newgard CB, Spiegelman BM. Control of hepatic gluconeogenesis through the transcriptional coaotivator PGC-1. Nature. 2001 ; 413(6852): 131-8. 

  52. Herzig S, Long F, Jhala US, Hedrick S, Quinn R, Bauer A, Rudolph D, Schutz G, Yoon C, Puigserver P, Spiegelman B, Montminy M. CREB regulates hepatic gluconeogenesis through the coactivator PGC-1. Nature. 2001 ; 413(6852):179-83. 

  53. Kim DK, Ryu DR, Koh MS, Lee MW, Lim DH, Kim MJ, Kim YH, Cho WJ, Lee CH, Park SB, Koo SH, Choi HS. Orphan nuclear receptor estro0gen-related receptor $\gamma$ (ERR $\gamma$ ) is key regulator of hepatic gluconeogenesis. J Biol Chem. 2012 ; 287(26): 21628-39. 

  54. Yoon KH, Lee HY, Jung YS, Seo BI, Park GR, Yoon MC, Shin SS. Modulation of obesity by Gyeongshingangjeehwan18 in ob/ob mice. Kor J Herbology. 2010;25(3):1-9. 

관련 콘텐츠

오픈액세스(OA) 유형

FREE

Free Access. 출판사/학술단체 등이 허락한 무료 공개 사이트를 통해 자유로운 이용이 가능한 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로